Noobiotik Intimate Flora vs. Probiotics Intimate Flora: which formula to choose in 2026?

75% of women experience an intimate imbalance during their lifetime ^¹. Noobiotik Flore Intime and SuperNutrition Probiotiques Flore Intime are among the leading references in this segment. We compared the two formulas strain by strain, without compromise.

Noobiotik Flore Intime vs SuperNutrition Probiotiques Flore Intime: the direct comparison

Both formulas share the same core: 5 Lactobacillus strains, patented gastro-resistant capsules, French manufacturing, and storage at room temperature. The differences lie in the specialized choices for each strain.

The fundamental difference is not in the number of strains—both formulas have 5—but in the dosage decisions. Noobiotik distributes its CFU budget across a broad spectrum, with high doses of L. reuteri and L. rhamnosus. Our Intimate Flora Probiotic concentrates most of its content on L. crispatus and adds L. helveticus as an exclusive antimicrobial strain.

L. crispatus: why dosage is the determining variable

Lactobacillus crispatus is the dominant strain of a healthy vaginal microbiota in most women. It produces lactic acid and hydrogen peroxide (H₂O₂), maintaining vaginal pH between 3.8 and 4.5. This acidic environment protects the Döderlein flora, which is hostile to undesirable microorganisms ^².

Our Intimate Flora Probiotic contains L. crispatus at 10 billion CFU, which is 43% more than Noobiotik (7 billion). This choice stems from a direct principle: the strain that naturally colonizes the vaginal mucosa should represent the dominant part of the formula, and not be diluted in favor of a more spectacular overall CFU volume.

L. helveticus: the antimicrobial asset absent in Noobiotik

Lactobacillus helveticus is naturally present in healthy vaginal flora. It stands out for its documented antimicrobial activity against Candida albicans, the fungus responsible for vaginal yeast infections ^³. Our Intimate Flora Probiotics include it at 2.5 billion CFU.

Noobiotik does not formulate with L. helveticus. In its place, L. casei (CNCM I-5094) is used, a strain more documented for intestinal microbiota and digestive immunity than specifically for the vaginal sphere. This is a consistent choice with a broad-spectrum approach, but it does not cover the same profile of intimate antimicrobial action.

The real advantages of Noobiotik Flore Intime

An honest comparison requires acknowledging the competitor's strengths. Noobiotik Flore Intime has real advantages that we document without minimizing.

25 billion CFU: volume as a formulation philosophy

Noobiotik doses its formula at 25 billion CFU for 2 capsules, compared to 20 billion for our Intimate Flora Probiotics. On the raw criterion of the number of active bacteria ingested per dose, Noobiotik is more generous. This approach is based on a broad coverage philosophy: to dose each strain strongly rather than concentrating on priority vaginal strains.

All strain codes published: a traceability signal

Noobiotik publishes the codes of each of its 5 strains directly on its product sheet: CNCM I-5095, CIRM-BIA 929, ATCC 53103, CNCM I-5094, ARS #B-3208. These strains are registered with the Pasteur Institute and INRAE, microorganism libraries recognized by French health authorities.

We provide analysis certificates for each batch via the dedicated tab on our product page. The publication of strain codes is a communication step that we are integrating into our transparency roadmap.

L. rhamnosus GG: what distinguishes it from a vaginal-specific strain?

The L. rhamnosus strain present in the Noobiotik formula is identified under the code ATCC 53103: this is L. rhamnosus GG, also known as LGG®. It is one of the most studied intestinal probiotic strains in the world, with over 1,000 referenced scientific publications.

A useful clarification for objective comparison: the combination of L. rhamnosus GR-1 and L. reuteri RC-14 is the most cited in the literature specifically dedicated to vaginal health via oral intake. GR-1 and GG are two distinct codes, two strains of the same species with potentially different colonization profiles depending on the targeted areas. This is not a flaw in the Noobiotik formula; it is a nuance to integrate into the comparison analysis.

1 capsule vs 2 capsules per day: a compliance criterion

Noobiotik recommends 2 capsules per day, in the morning before breakfast. Our Intimate Flora Probiotic is administered as 1 capsule per day, with the same recommended timing.

Over a 3-month course, the difference is 180 capsules versus 90. Compliance, meaning the regularity of daily intake, is the determining factor for achieving sustainable microbiota colonization. A simple dosage reduces the risk of forgetting, especially during long preventive courses.

Both formulas protect their strains with different patented technologies: Embo Caps® for Noobiotik, DRcaps® for us. Both are designed to resist gastric acidity and release the strains in the intestine. No direct comparative data between the two technologies is available to evaluate the superiority of one over the other.

Noobiotik also offers a reduced dosage of 1 capsule/day for adolescents over 12, which our Intimate Flora Probiotic does not explicitly detail; this is a communication point to be completed on our product page.

Who should choose each formula?

Both products aim to balance the vaginal microbiota through oral intake. Usage profiles differ according to your priorities.

You might consider Noobiotik Flore Intime if...

• You want one of the highest total CFU volumes on the market (25 billion per dose)
• The publication of strain codes is a selection criterion in your purchasing decision
• You are looking for broad coverage of L. reuteri and L. rhamnosus in addition to L. crispatus
• You want a product available through a wide distribution network

Our Intimate Flora Probiotic is suitable if...

• You want the highest concentration of L. crispatus (10 billion CFU, the dominant strain of a healthy vaginal microbiota)
• You are prone to recurrent yeast infections and wish to include L. helveticus in your course of treatment
• You prefer a dosage of 1 capsule per day to facilitate regularity over time
• You wish to access the analysis certificates for each production batch

The two formulas are compatible with each other. If you wish to combine them, a spacing of 1 to 2 hours between doses is sufficient. No documented interaction exists between the strains of the two products.

Frequently Asked Questions

Is Noobiotik Flore Intime effective for vaginal flora?

Noobiotik Flore Intime is a food supplement formulated for the female vaginal microbiota. It contains documented Lactobacillus strains, including L. crispatus. Like any supplement, it helps support microbiota balance; it does not treat infections and does not replace medical advice.

What is the real difference in L. crispatus between the two formulas?

Our Intimate Flora Probiotic contains L. crispatus at 10 billion CFU per capsule, compared to 7 billion in Noobiotik. This 43% difference concerns the strain most represented in a healthy vaginal microbiota according to available scientific data.

L. helveticus, what is this strain used for in intimate flora?

Lactobacillus helveticus is naturally present in healthy vaginal flora. It is documented for its antimicrobial activity, particularly against Candida albicans, responsible for yeast infections. It is present in our Intimate Flora Probiotic and absent from the Noobiotik formula.

Can Noobiotik Flore Intime and Intimate Flora Probiotic be taken simultaneously?

Yes, the two formulas are compatible. A spacing of 1 to 2 hours between doses is recommended. No interaction between their respective strains is documented. If in doubt, consult your doctor.

Which intimate flora probiotic contains the most L. crispatus?

Among the two products compared in this article, our Intimate Flora Probiotic concentrates L. crispatus at 10 billion CFU compared to 7 billion in Noobiotik. L. crispatus is the strain most associated with the stability of the protective vaginal microbiota in 2024-2025 data.